1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > CNS Drug News 03 AUGUST 2015

CNS Drug News 03 AUGUST 2015

  • August 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - M&A Activity Ahead For Biogen
Industry Brief - Osmolex ER Awarded FDA ODD
Industry Trend Analysis - Data Keep Hopes Alive For Lilly's Solanezumab
Industry Brief - Isis Earns Milestone From Roche With ISIS-HTTRx Phase I/IIa Study Initiation
Industry Brief - MHRA Review Confirms Benefit/Risk Profile Of BI's Alteplase
Industry Brief - ANI/Sofgen Gain US Nimodipine Approval
Industry Brief - ICT Proceeding With ITI-007 Phase III Development For Bipolar Depression
Industry Brief - Neos Resubmits NDA For Amphetamine XR-ODT To Treat ADHD
Industry Brief - FDA Approves Deltoid Injection Site For Abilify Maintena
Industry Brief - CHMP Adopts Positive Opinion For Zalviso
Industry Brief - Elite Completes Enrolment And Dosing For ELI-200 Phase III Efficacy Trial
Industry Brief - PAION Completes Remimazolam Know-How/Technology Transfer From Ono
Industry Brief - Adapt Pharma Submits NDA For Narcan Nasal Spray
Industry Trend Analysis - 3D Printing Will Play Part In Future Of Personalised Medicine
Industry Brief - Eisai Submits Fycompa NDA In Japan For Partial Onset/PGTC Seizures
Industry Brief - Shire Reports Positive Top-Line Results From Vyvanse Maintenance Of Efficacy Study In BED
Industry Brief - Galena Launches Zuplenz In US
Industry Brief - Tesaro/Hengrui Announce Rolapitant Licence Agreement For China
Industry Brief - JCR/Eisai Conclude Feasibility Study Agreement On Application Of BBB Penetration Technology
Industry Trend Analysis - Allergan Strengthens Mental Health Pipeline But Transformational Deal Ahead
Industry Trend Analysis - Core Medicines To Drive Overall Growth For UCB

Table Of Contents

CNS Drug News 03 AUGUST 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Alcoholism and drug dependence and addiction, known as substance use disorders and rehabilitation treatments are classified as substance abuse treatment. Some of the common symptoms of drug abuse are ...

Psychotherapeutic Drugs Market: By Type (Antipsychotics, Antidepressants, Antimaniacs, and Anxiety Drugs) & By Geography -Forecast (2016-2021)

Psychotherapeutic Drugs Market: By Type (Antipsychotics, Antidepressants, Antimaniacs, and Anxiety Drugs) & By Geography -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • August 2016
  • by Industry ARC

Psychotherapeutic drugs are used to treat mental illnesses such as extreme mood swings, social withdrawal, long lasting depression, confused thinking, and suicidal thought. schizophrenia, bipolar disorder, ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.